Sandra Parra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sandra Parra has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Alonso-Villaverde
Institut Català de Ciències Cardiovasculars, Centre superior d'Investigacions Científiques, Barcelona, Spain
16 shared publications - Jorge Joven
Unitat de Recerca Biomédica, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
12 shared publications - Antoni Castro
Autoimmunity, Infection and Thrombosis Research Group (GRAIIT), Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut de Recerca Biomèdica Catalunya Sud, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
9 shared publications Lluis Masana
Servei de Medicina Interna, Hospital Universitari Sant Joan, Universitat Rovira i Virgili, 43201 Reus, Tarragona, Spain
9 shared publicationsBlai Coll
Institut de Recerca Biomèdica, Hospital Arnau Vilanova, Lleida, Spain Lleida, Spain
8 shared publications- Gerard Aragonès
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Nutrigenomics Research Group, C/Marcel·lí Domingo 1, 43007, Tarragona, Spain
8 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Admission lipid profile and outcomes in sepsis requiring early invasive source control
Lipid metabolism is profoundly altered in sepsis, but its prognostic utility is underused in clinical practice. We evaluated lipid profiles performed within 24-48 h of ICU admission in patients with sepsis or septic shock who had already undergone surgical or interventional source control and explored associations with organ support and hospital mortality. We conducted a single-center retrospective observational cohort study at the intensive care unit of Hospital Universitari Sant Joan de Reus (2016-2023). We included adults meeting Sepsis-3 criteria who underwent surgical or interventional source control within 48 h of hospital arrival. Only patients with available lipid profiles were included, which may introduce selection bias. Hospital mortality was defined as the primary clinical outcome. Secondary outcomes included organ support requirements, ICU and hospital length of stay, correlations with SOFA severity scores, and inflammatory biomarkers. Multivariable logistic regression models were constructed as an exploratory analysis to investigate the independent associations between lipid parameters and hospital mortality. Of 266 screened patients, 150 met the inclusion criteria, comprising 61.3% males, with a median age of 72.1 years (IQR, 61.7-79.8), and an overall hospital mortality rate of 18.7% (n = 28). Non-survivors exhibited significantly lower concentrations of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol levels, and higher triglyceride levels than survivors. In ROC analyses, HDL-C showed the highest accuracy (AUC 0.966, 95% CI 0.904-1.000), with an optimal cutoff of 15 mg/dL, sensitivity of 96.4%, and specificity of 98.3%. This was followed by total cholesterol (AUC 0.963, 95% CI 0.901-1.000) and LDL-C (AUC 0.920, 95% CI 0.851-0.989). In contrast, triglycerides demonstrated a more modest predictive performance (AUC 0.849, 95% CI 0.772-0.926). In multivariable analysis, lower HDL-C levels (OR 0.802, 95% CI 0.727-0.885; p < 0.001) and lower albumin levels (OR 0.241, 95% CI 0.066-0.879; p = 0.031) remained independently associated with hospital mortality in the final parsimonious model derived using backward stepwise selection from an initial candidate model including chronic kidney disease, CRRT requirement, vasopressor use, LDL-C, VLDL-C, and triglycerides. Early hypolipidemia was independently associated with hospital mortality in septic patients undergoing timely source control. Post-source control lipid alterations may reflect residual immunometabolic vulnerability and warrant further evaluation as exploratory prognostic biomarkers. Nevertheless, given the retrospective observational design and limited sample size, these results should be interpreted as hypothesis-generating and require prospective external validation. Not applicable.
- 15 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessAdmission lipid profile and outcomes in sepsis requiring early invasive source control
Lipid metabolism is profoundly altered in sepsis, but its prognostic utility is underused in clinical practice. We evaluated lipid profiles performed within 24-48 h of ICU admission in patients with sepsis or septic shock who had already undergone surgical or interventional source control and explored associations with organ support and hospital mortality. We conducted a single-center retrospective observational cohort study at the intensive care unit of Hospital Universitari Sant Joan de Reus (2016-2023). We included adults meeting Sepsis-3 criteria who underwent surgical or interventional source control within 48 h of hospital arrival. Only patients with available lipid profiles were included, which may introduce selection bias. Hospital mortality was defined as the primary clinical outcome. Secondary outcomes included organ support requirements, ICU and hospital length of stay, correlations with SOFA severity scores, and inflammatory biomarkers. Multivariable logistic regression models were constructed as an exploratory analysis to investigate the independent associations between lipid parameters and hospital mortality. Of 266 screened patients, 150 met the inclusion criteria, comprising 61.3% males, with a median age of 72.1 years (IQR, 61.7-79.8), and an overall hospital mortality rate of 18.7% (n = 28). Non-survivors exhibited significantly lower concentrations of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol levels, and higher triglyceride levels than survivors. In ROC analyses, HDL-C showed the highest accuracy (AUC 0.966, 95% CI 0.904-1.000), with an optimal cutoff of 15 mg/dL, sensitivity of 96.4%, and specificity of 98.3%. This was followed by total cholesterol (AUC 0.963, 95% CI 0.901-1.000) and LDL-C (AUC 0.920, 95% CI 0.851-0.989). In contrast, triglycerides demonstrated a more modest predictive performance (AUC 0.849, 95% CI 0.772-0.926). In multivariable analysis, lower HDL-C levels (OR 0.802, 95% CI 0.727-0.885; p < 0.001) and lower albumin levels (OR 0.241, 95% CI 0.066-0.879; p = 0.031) remained independently associated with hospital mortality in the final parsimonious model derived using backward stepwise selection from an initial candidate model including chronic kidney disease, CRRT requirement, vasopressor use, LDL-C, VLDL-C, and triglycerides. Early hypolipidemia was independently associated with hospital mortality in septic patients undergoing timely source control. Post-source control lipid alterations may reflect residual immunometabolic vulnerability and warrant further evaluation as exploratory prognostic biomarkers. Nevertheless, given the retrospective observational design and limited sample size, these results should be interpreted as hypothesis-generating and require prospective external validation. Not applicable.
- Open Access
- 3 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0341192
Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition
The development and persistence of symptoms following SARS-CoV-2 infection, known as Post-COVID-19 Condition (PCC) or “long COVID,” represents a global health challenge. In this prospective cross-sectional study, we conducted a detailed assessment of the physical condition of 46 patients using handgrip dynamometry, ergoespirometry, and the 6-minute walk test (6MWT). The results revealed a loss of muscle strength and poor exercise tolerance primarily due to peripheral muscle involvement. To complement and better understand these findings, we compared the blood metabolome and lipidome of 13 patients with PCC, 13 patients with acute COVID-19 infection, and 13 healthy controls using magnetic resonance spectroscopy (1H-NMR). PCC patients showed lower levels of HDL-cholesterol, as well as medium and dense HDL particles, which could contribute to a pro-atherogenic and pro-inflammatory state. Although no significant differences were observed in glycoproteins, we found decreased glucose and increased lactate levels, supporting the hypothesis of mitochondrial dysfunction in PCC patients. Additionally, elevated glycine and reduced glutamate levels may be related to the neurological symptoms associated with the condition. We also observed increased levels of glutamine, leucine, and isoleucine, indicating protein hypercatabolism and metabolic stress. These findings suggest that alterations in the metabolome and lipidome of PCC patients may be contributing to the persistence of their symptoms.
- 3 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0341192
Open AccessAssessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition
The development and persistence of symptoms following SARS-CoV-2 infection, known as Post-COVID-19 Condition (PCC) or “long COVID,” represents a global health challenge. In this prospective cross-sectional study, we conducted a detailed assessment of the physical condition of 46 patients using handgrip dynamometry, ergoespirometry, and the 6-minute walk test (6MWT). The results revealed a loss of muscle strength and poor exercise tolerance primarily due to peripheral muscle involvement. To complement and better understand these findings, we compared the blood metabolome and lipidome of 13 patients with PCC, 13 patients with acute COVID-19 infection, and 13 healthy controls using magnetic resonance spectroscopy (1H-NMR). PCC patients showed lower levels of HDL-cholesterol, as well as medium and dense HDL particles, which could contribute to a pro-atherogenic and pro-inflammatory state. Although no significant differences were observed in glycoproteins, we found decreased glucose and increased lactate levels, supporting the hypothesis of mitochondrial dysfunction in PCC patients. Additionally, elevated glycine and reduced glutamate levels may be related to the neurological symptoms associated with the condition. We also observed increased levels of glutamine, leucine, and isoleucine, indicating protein hypercatabolism and metabolic stress. These findings suggest that alterations in the metabolome and lipidome of PCC patients may be contributing to the persistence of their symptoms.
- Open Access
- 8 November 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 423, 111808
Corrigendum to “Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia” [Chem. Biol. Interact. 418 (2025) 111606]
- 8 November 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 423, 111808
Open AccessCorrigendum to “Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia” [Chem. Biol. Interact. 418 (2025) 111606]
- Open Access
- 12 June 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 418, 111606
Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia
- 12 June 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 418, 111606
Open AccessInsights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia
- Open Access
- 22 August 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (9) , 100622
Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia
- 22 August 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (9) , 100622
Open AccessLipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia
- 20 July 2023
- Published by Taylor & Francis in Infectious Diseases
- Vol. 55 (11) , 798-802
Report on the first two confirmed autochthonous cases of West Nile virus encephalitis in Catalonia, Spain
West Nile virus (WNV) is a mosquito-borne flavivirus that can cause Central Nervous System infection in humans. Previous autochthonous cases of WNV encephalitis have been described in Spain, but none in Catalonia. We report on the first two autochthonous cases of encephalitis in humans caused by the West Nile virus (WNV) diagnosed in Catalonia (northeastern region of Spain). An old married couple presented with clinical and biological signs compatible with viral encephalitis. Acute and convalescent serum samples showed IgM and IgG positivity for WNV. In addition, IgM was also detected in cerebrospinal fluid in the male patient. The serological results were later confirmed by microneutralization assays. WNV infection must be considered in patients presenting with meningoencephalitis with viral CSF characteristics when common pathogens are excluded.
- 20 July 2023
- Published by Taylor & Francis in Infectious Diseases
- Vol. 55 (11) , 798-802
Report on the first two confirmed autochthonous cases of West Nile virus encephalitis in Catalonia, Spain
West Nile virus (WNV) is a mosquito-borne flavivirus that can cause Central Nervous System infection in humans. Previous autochthonous cases of WNV encephalitis have been described in Spain, but none in Catalonia. We report on the first two autochthonous cases of encephalitis in humans caused by the West Nile virus (WNV) diagnosed in Catalonia (northeastern region of Spain). An old married couple presented with clinical and biological signs compatible with viral encephalitis. Acute and convalescent serum samples showed IgM and IgG positivity for WNV. In addition, IgM was also detected in cerebrospinal fluid in the male patient. The serological results were later confirmed by microneutralization assays. WNV infection must be considered in patients presenting with meningoencephalitis with viral CSF characteristics when common pathogens are excluded.
- Open Access
- 6 March 2023
- Published by Elsevier in Atherosclerosis Plus
- Vol. 52, 1-8
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease
- 6 March 2023
- Published by Elsevier in Atherosclerosis Plus
- Vol. 52, 1-8
Open AccessLow HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease
- Open Access
Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection—A Preliminary Report
The pandemic caused by the SARS-CoV-2 infection affects many aspects of public health knowledge, science, and practice around the world. Several studies have shown that SARS-CoV-2 RNA in plasma seems to be associated with a worse prognosis of COVID-19. In the present study, we investigated plasma and buffy RNA in patients with COVID-19 to determine its prognostic value. A prospective study was carried out in patients hospitalized for COVID-19, in which RNA was analyzed in plasma and the buffy coat. Morphological and immunohistochemical studies were used to detect the presence of SARS-CoV-2 in the buffy coat. In COVID-19 patients, the obtained RNA concentration in plasma was 448.3 ± 31.30 ng/mL. Of all the patients with positive plasma tests for SARS-CoV-2, 46.15% died from COVID-19. In four cases, tests revealed that SARS-CoV-2 was present in the buffy coat. Abnormal morphology of monocytes, lymphocytes and neutrophils was found. An immunohistochemical study showed positivity in mononuclear cells and platelets. Our results suggest that SARS-CoV-2 is present in the plasma. This facilitates viral dissemination and migration to specific organs, where SARS-CoV-2 infects target cells by binding to their receptors. In our study, the presence of plasma SARS-CoV-2 RNA was correlated with worse prognoses.
Open AccessStudy of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection—A Preliminary Report
The pandemic caused by the SARS-CoV-2 infection affects many aspects of public health knowledge, science, and practice around the world. Several studies have shown that SARS-CoV-2 RNA in plasma seems to be associated with a worse prognosis of COVID-19. In the present study, we investigated plasma and buffy RNA in patients with COVID-19 to determine its prognostic value. A prospective study was carried out in patients hospitalized for COVID-19, in which RNA was analyzed in plasma and the buffy coat. Morphological and immunohistochemical studies were used to detect the presence of SARS-CoV-2 in the buffy coat. In COVID-19 patients, the obtained RNA concentration in plasma was 448.3 ± 31.30 ng/mL. Of all the patients with positive plasma tests for SARS-CoV-2, 46.15% died from COVID-19. In four cases, tests revealed that SARS-CoV-2 was present in the buffy coat. Abnormal morphology of monocytes, lymphocytes and neutrophils was found. An immunohistochemical study showed positivity in mononuclear cells and platelets. Our results suggest that SARS-CoV-2 is present in the plasma. This facilitates viral dissemination and migration to specific organs, where SARS-CoV-2 infects target cells by binding to their receptors. In our study, the presence of plasma SARS-CoV-2 RNA was correlated with worse prognoses.
- 26 August 2020
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 60 (2) , 866-871
Low-density lipoprotein from active SLE patients is more atherogenic to endothelial cells than low-density lipoprotein from the same patients during remission
Objectives: SLE patients have an enhanced risk of atherosclerosis and cardiovascular disease. However, the increased prevalence of cardiovascular disease is not fully explained by traditional Framingham cardiovascular risk factors. Specific features of low-density lipoprotein (LDL) particles, other than plasma concentration, may induce accelerated atherosclerosis at early stages in these patients. Thus, we aimed to explore the impact of LDL from both active and inactive SLE patients on human aortic endothelial cells. Methods: Human aortic endothelial cells were stimulated with the same concentration of LDL particles isolated from pooled serum that was collected from 13 SLE patients during both active and inactive states. Gene expression and cell migration assays were performed. Results: Circulating LDL particles obtained from healthy volunteers and SLE patients in both remission and flare states were comparable in terms of number, cholesterol and triglyceride content, and net electric charge. Stimulation of cells with LDL from active SLE patients induced the expression of vascular cell adhesion molecule 1 (∼2.0-fold, P < 0.05), monocyte chemoattractant protein 1 (∼2.0-fold, P < 0.05) and matrix metallopeptidase 2 (∼1.6-fold, P < 0.01) compared with cells stimulated with LDL from inactive SLE patients. Additionally, LDL extracted from active patients increased cell migration in a wound-healing assay (1.4-fold, P < 0.05). Conclusion: Our data show that, at the same LDL concentration, LDL from active SLE patients had increased proatherogenic effects on endothelial cells compared with LDL from the same patients when in an inactive or remission state.
- 26 August 2020
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 60 (2) , 866-871
Low-density lipoprotein from active SLE patients is more atherogenic to endothelial cells than low-density lipoprotein from the same patients during remission
Objectives: SLE patients have an enhanced risk of atherosclerosis and cardiovascular disease. However, the increased prevalence of cardiovascular disease is not fully explained by traditional Framingham cardiovascular risk factors. Specific features of low-density lipoprotein (LDL) particles, other than plasma concentration, may induce accelerated atherosclerosis at early stages in these patients. Thus, we aimed to explore the impact of LDL from both active and inactive SLE patients on human aortic endothelial cells. Methods: Human aortic endothelial cells were stimulated with the same concentration of LDL particles isolated from pooled serum that was collected from 13 SLE patients during both active and inactive states. Gene expression and cell migration assays were performed. Results: Circulating LDL particles obtained from healthy volunteers and SLE patients in both remission and flare states were comparable in terms of number, cholesterol and triglyceride content, and net electric charge. Stimulation of cells with LDL from active SLE patients induced the expression of vascular cell adhesion molecule 1 (∼2.0-fold, P < 0.05), monocyte chemoattractant protein 1 (∼2.0-fold, P < 0.05) and matrix metallopeptidase 2 (∼1.6-fold, P < 0.01) compared with cells stimulated with LDL from inactive SLE patients. Additionally, LDL extracted from active patients increased cell migration in a wound-healing assay (1.4-fold, P < 0.05). Conclusion: Our data show that, at the same LDL concentration, LDL from active SLE patients had increased proatherogenic effects on endothelial cells compared with LDL from the same patients when in an inactive or remission state.
- 23 August 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (3) , 650-661
Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c
Objectives: To identify potential biomarkers of disease activity analysing the proteome of high-density lipoprotein (HDL) particles from SLE patients in clinical remission and when they develop a flare compared with a healthy control group.Methods: Quantitative proteomic analyses of purified HDL were performed using Tandem Mass Tag isobaric tag-labelling and nanoLC-Orbitrap (nLC-MS/MS) from nine SLE patients in clinical remission when they developed a flare and from nine healthy controls (9–9-9). We verified the identified proteins by Western blot and ELISA in a cohort of 104 SLE women patients, 46 healthy women and 14 SLE patients when a flare developed.Results: We found 17 proteins with a significant fold-change (>1.1) compared with the control group. In lupus patients experiencing a flare compared with those in remission, we identified four proteins with a significant fold-change (C4, Indian Hedgehog protein, S100A8 and gelsolin). Plasma gelsolin (pGSN) levels were decreased in the 104 SLE patients (176.02(74.9) mcg/l) compared with the control group (217.13(86.7) mcg/l); P=0.005 and when they developed a clinical flare (104.84(41.7) mcg/l); P=0.002). pGSN levels were associated with HDL cholesterol levels (r = 0.316, P<0.001). Antimalarial treated patients showed significant higher levels of pGSN (214.56(88.94) mcg/l regarding 170.35(66.36) mcg/l); P = 0.017.Conclusion: Decreased pGSN are associated with clinical disease activity in SLE patients. Antimalarial treatment and HDL cholesterol are associated with higher levels of pGSN.
- 23 August 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (3) , 650-661
Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c
Objectives: To identify potential biomarkers of disease activity analysing the proteome of high-density lipoprotein (HDL) particles from SLE patients in clinical remission and when they develop a flare compared with a healthy control group.Methods: Quantitative proteomic analyses of purified HDL were performed using Tandem Mass Tag isobaric tag-labelling and nanoLC-Orbitrap (nLC-MS/MS) from nine SLE patients in clinical remission when they developed a flare and from nine healthy controls (9–9-9). We verified the identified proteins by Western blot and ELISA in a cohort of 104 SLE women patients, 46 healthy women and 14 SLE patients when a flare developed.Results: We found 17 proteins with a significant fold-change (>1.1) compared with the control group. In lupus patients experiencing a flare compared with those in remission, we identified four proteins with a significant fold-change (C4, Indian Hedgehog protein, S100A8 and gelsolin). Plasma gelsolin (pGSN) levels were decreased in the 104 SLE patients (176.02(74.9) mcg/l) compared with the control group (217.13(86.7) mcg/l); P=0.005 and when they developed a clinical flare (104.84(41.7) mcg/l); P=0.002). pGSN levels were associated with HDL cholesterol levels (r = 0.316, P<0.001). Antimalarial treated patients showed significant higher levels of pGSN (214.56(88.94) mcg/l regarding 170.35(66.36) mcg/l); P = 0.017.Conclusion: Decreased pGSN are associated with clinical disease activity in SLE patients. Antimalarial treatment and HDL cholesterol are associated with higher levels of pGSN.